CN Stock MarketDetailed Quotes
300550 Heren Health
- 14.61
- -0.50-3.31%
Market Closed Nov 15 15:00 CST
3.84BMarket Cap141.84P/E (TTM)
15.29High14.60Low53.58KlotVolume15.18Open15.11Pre Close80.06MTurnover2.04%Turnover Ratio98.05P/E (Static)262.56MShares16.2452wk High3.58P/B3.83BFloat Cap7.0052wk Low18.13Limit Up262.32MShs Float39.99Historical High12.09Limit Down4.57%Amplitude5.84Historical Low0.03Dividend TTM14.94Avg Price28.32KlotAsk0.21%Div YieldTTM100Lot Size23.80KlotBid
Heren Health Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -6.42%264.32M | -10.21%160.46M | -8.50%91.15M | 21.90%439.25M | -6.76%282.45M | -14.16%178.71M | 3.24%99.61M | -22.38%360.33M | -0.98%302.92M | 8.56%208.18M |
| Operating revenue | -6.42%264.32M | -10.21%160.46M | -8.50%91.15M | 21.90%439.25M | -6.76%282.45M | -14.16%178.71M | 3.24%99.61M | -22.38%360.33M | -0.98%302.92M | 8.56%208.18M |
| Other operating revenue | ---- | 30.38%6.13M | ---- | -36.17%9.5M | ---- | -31.45%4.7M | ---- | 10.85%14.88M | ---- | -2.11%6.86M |
| Total operating cost | -11.07%237.76M | -9.52%168.68M | -14.50%90.77M | -6.16%398.43M | 2.33%267.34M | 0.39%186.43M | 15.83%106.16M | -0.92%424.57M | -3.99%261.26M | 5.66%185.71M |
| Operating cost | -14.40%149.41M | -8.95%110.82M | -9.45%65.34M | -6.41%268.3M | 4.63%174.54M | -0.20%121.7M | 20.44%72.15M | -5.40%286.67M | -7.10%166.82M | 4.24%121.94M |
| Operating tax surcharges | 5.26%4.04M | 9.19%2.49M | 0.57%1.37M | 0.49%6.34M | -28.02%3.84M | -40.48%2.28M | -33.46%1.36M | 7.91%6.31M | 17.79%5.34M | 29.66%3.82M |
| Operating expense | 7.96%15.99M | -2.15%10.67M | -22.60%4.65M | -25.80%23.95M | -23.78%14.81M | -11.38%10.91M | 3.25%6.01M | 7.51%32.27M | -11.93%19.43M | -9.69%12.31M |
| Administration expense | -25.43%33.78M | -30.10%22.84M | -32.64%9.57M | 12.31%57.02M | 26.76%45.3M | 38.19%32.68M | 54.17%14.21M | 31.27%50.77M | 7.40%35.73M | 5.85%23.65M |
| Financial expense | 53.33%-4.03M | 52.57%-3.09M | 15.60%-1.81M | -99.21%-10.99M | -36.38%-8.63M | -175.20%-6.52M | -510.91%-2.14M | -90.02%-5.52M | -166.52%-6.32M | -71.26%-2.37M |
| -Interest expense (Financial expense) | -1.25%3.3M | -8.05%2.19M | -13.07%1.13M | 10.75%3.86M | 50.86%3.34M | 104.30%2.39M | 152.74%1.29M | 37.88%3.49M | 17.83%2.22M | -21.73%1.17M |
| -Interest Income (Financial expense) | 38.75%-7.37M | 40.62%-5.31M | 14.75%-2.95M | -64.27%-14.92M | -39.76%-12.03M | -149.69%-8.95M | -273.51%-3.46M | -60.99%-9.08M | -94.34%-8.61M | -20.88%-3.58M |
| Research and development | 2.90%38.56M | -1.67%24.95M | -20.08%11.64M | -0.45%53.81M | -6.91%37.48M | -3.70%25.38M | -2.98%14.57M | 0.42%54.05M | 14.86%40.26M | 24.10%26.35M |
| Credit Impairment Loss | -1,557.92%-22.54M | -812.31%-11.94M | -137.16%-1.48M | 52.73%-12.22M | 92.97%-1.36M | 86.29%-1.31M | 476.25%3.99M | -212.29%-25.86M | -950.67%-19.34M | -243.53%-9.54M |
| Asset Impairment Loss | 10.64%-8.12M | -1,560.12%-922.87K | -4,810.58%-1.23M | 73.83%-5.3M | -35.26%-9.08M | 104.40%63.21K | 104.68%26.09K | -121.34%-20.27M | -53.47%-6.72M | 17.39%-1.44M |
| Other net revenue | -2,057.34%-25.55M | -305.87%-9.31M | -110.71%-819.19K | 102.37%725.5K | 92.50%-1.18M | 275.03%4.52M | 515.80%7.65M | -4,672.38%-30.57M | -509.77%-15.8M | -171.05%-2.58M |
| Fair value change income | 67.86%798.89K | 187.96%798.89K | 450.54%410.76K | 399.65%724K | --475.92K | --277.43K | --74.61K | --144.9K | ---- | ---- |
| Invest income | -91.47%35.96K | 12.25%420.78K | -46.82%216.9K | -84.23%413.29K | -86.44%421.62K | -87.94%374.87K | -65.46%407.86K | -67.71%2.62M | -49.49%3.11M | -26.48%3.11M |
| -Including: Investment income associates | ---335.86K | ---1.91K | ---- | --1.91K | ---- | ---- | ---- | --0 | ---- | ---- |
| Asset deal income | 281.62%144.66K | 86.45%-9.84K | 90.82%-4.23K | -188.42%-103.52K | 91.72%-79.65K | -122.42%-72.64K | -320.54%-46.06K | 18.77%-35.89K | -2,473.02%-961.41K | -17.36%-32.66K |
| Other revenue | -51.16%4.12M | -54.80%2.34M | -60.43%1.27M | 34.26%17.22M | 4.02%8.44M | -2.48%5.19M | 89.64%3.2M | 46.98%12.82M | 105.23%8.11M | 34.64%5.32M |
| Operating profit | -92.78%1.01M | -448.21%-17.53M | -139.87%-438.48K | 143.82%41.54M | -46.17%13.92M | -116.08%-3.2M | -81.90%1.1M | -370.50%-94.81M | -31.33%25.87M | 1.22%19.89M |
| Add:Non operating Income | --113.81K | --93.81K | --4.05K | -99.92%100 | ---- | ---- | ---- | 1,563.99%129.83K | 1,563.99%129.83K | 1,564.17%129.83K |
| Less:Non operating expense | -64.44%103.12K | -82.06%18.36K | 109.53%11.79K | 55.32%572.65K | 445.96%289.98K | 127.00%102.34K | -88.52%5.63K | 214.54%368.69K | 52.90%53.11K | 119.43%45.08K |
| Total profit | -92.54%1.02M | -428.92%-17.45M | -140.79%-446.22K | 143.11%40.97M | -47.45%13.63M | -116.52%-3.3M | -82.23%1.09M | -372.03%-95.05M | -31.08%25.94M | 1.72%19.97M |
| Less:Income tax cost | -21.65%493.59K | -217.66%-2.9M | -296.20%-105.22K | 118.87%2.05M | -68.53%629.99K | -154.13%-911.45K | -95.35%53.63K | -1,767.60%-10.85M | -29.59%2M | 105.75%1.68M |
| Net profit | -95.98%522.95K | FPtoL-14.56M | SL-341K | FLtoP38.92M | -45.68%13M | SL-2.39M | -79.19%1.04M | SL-84.2M | -31.20%23.94M | -2.80%18.29M |
| Net profit from continuing operation | -95.98%522.95K | -509.55%-14.56M | -132.78%-341K | 146.23%38.92M | -45.68%13M | -113.06%-2.39M | -79.19%1.04M | -345.55%-84.2M | -31.20%23.94M | -2.80%18.29M |
| Less:Minority Profit | -263.79%-406.3K | -153.56%-223.66K | 108.78%174.98K | 78.34%-192.95K | 86.85%-111.68K | 90.80%-88.21K | 113.70%83.81K | -362.20%-890.88K | -223.86%-849.18K | -397.79%-959K |
| Net profit of parent company owners | -92.92%929.24K | -523.20%-14.33M | -153.94%-515.98K | 146.95%39.12M | -47.09%13.12M | -111.95%-2.3M | -82.96%956.61K | -341.60%-83.31M | -29.29%24.79M | 1.26%19.25M |
| Earning per share | ||||||||||
| Basic earning per share | -93.00%0.0035 | -400.00%-0.05 | -155.56%-0.002 | 146.88%0.15 | -44.44%0.05 | -114.29%-0.01 | -83.18%0.0036 | -346.15%-0.32 | -30.77%0.09 | 0.00%0.07 |
| Diluted earning per share | -93.00%0.0035 | -400.00%-0.05 | -155.56%-0.002 | 146.88%0.15 | -44.44%0.05 | -114.29%-0.01 | -82.00%0.0036 | -346.15%-0.32 | -30.77%0.09 | 0.00%0.07 |
| Other composite income | ||||||||||
| Total composite income | -95.98%522.95K | -509.55%-14.56M | -132.78%-341K | 146.23%38.92M | -45.68%13M | -113.06%-2.39M | -79.19%1.04M | -345.55%-84.2M | -31.20%23.94M | -2.80%18.29M |
| Total composite income of parent company owners | -92.92%929.24K | -523.20%-14.33M | -153.94%-515.98K | 146.95%39.12M | -47.09%13.12M | -111.95%-2.3M | -82.96%956.61K | -341.60%-83.31M | -29.29%24.79M | 1.26%19.25M |
| Total composite income of minority owners | -263.79%-406.3K | -153.56%-223.66K | 108.78%174.98K | 78.34%-192.95K | 86.85%-111.68K | 90.80%-88.21K | 113.70%83.81K | -362.20%-890.88K | -223.86%-849.18K | -397.79%-959K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data